Abstract

Chronic lung diseases, including chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease, pose significant global health challenges due to their prevalence, impact on quality of life, and high economic burden. This article provides a comprehensive review of the current understanding of the pathophysiology of these conditions, highlighting the underlying mechanisms that contribute to disease progression. It also explores recent advancements in management strategies, including pharmacological interventions, non-pharmacological therapies, and emerging treatments. The review emphasizes the importance of personalized medicine and interdisciplinary approaches in managing chronic lung diseases effectively. Advances in diagnostic tools and therapeutic options offer hope for improved patient outcomes, although challenges remain in implementing these innovations universally. This article aims to bridge the gap between current research and clinical practice, providing healthcare professionals with updated knowledge and insights into optimizing patient care.